SynthesisFrontiers in endocrinology2026
CagriSema versus Semaglutide 2.4 mg monotherapy for weight management in adults with overweight or obesity, with or without type 2 diabetes: a systematic review, meta-analysis, and trial sequential analysis.
Zehra Khatoon Rasool et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.